227 related articles for article (PubMed ID: 25113908)
1. HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain.
Bolduan S; Reif T; Schindler M; Schubert U
Virology; 2014 Sep; 464-465():375-384. PubMed ID: 25113908
[TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
Matusali G; Potestà M; Santoni A; Cerboni C; Doria M
J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152
[TBL] [Abstract][Full Text] [Related]
3. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
4. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
[TBL] [Abstract][Full Text] [Related]
5. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R; Neil SJ
J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
[TBL] [Abstract][Full Text] [Related]
6. Lack of adaptation to human tetherin in HIV-1 group O and P.
Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM
Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.
Magadán JG; Bonifacino JS
J Virol; 2012 Jan; 86(2):757-72. PubMed ID: 22090097
[TBL] [Abstract][Full Text] [Related]
8. Vpu binds directly to tetherin and displaces it from nascent virions.
McNatt MW; Zang T; Bieniasz PD
PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949
[TBL] [Abstract][Full Text] [Related]
9. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4
Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD
Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537
[TBL] [Abstract][Full Text] [Related]
10. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.
Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625
[TBL] [Abstract][Full Text] [Related]
11. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.
Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J
mBio; 2019 Jun; 10(3):. PubMed ID: 31213558
[TBL] [Abstract][Full Text] [Related]
13. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.
Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT
J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785
[TBL] [Abstract][Full Text] [Related]
14. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.
Lambelé M; Koppensteiner H; Symeonides M; Roy NH; Chan J; Schindler M; Thali M
J Virol; 2015 Mar; 89(6):3247-55. PubMed ID: 25568205
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.
Rong L; Zhang J; Lu J; Pan Q; Lorgeoux RP; Aloysius C; Guo F; Liu SL; Wainberg MA; Liang C
J Virol; 2009 Aug; 83(15):7536-46. PubMed ID: 19474106
[TBL] [Abstract][Full Text] [Related]
16. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.
Bächle SM; Sauter D; Sibitz S; Sandberg JK; Kirchhoff F; Moll M
Sci Rep; 2015 Apr; 5():9675. PubMed ID: 25872908
[TBL] [Abstract][Full Text] [Related]
18. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.
Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D
mBio; 2020 Jul; 11(4):. PubMed ID: 32665270
[TBL] [Abstract][Full Text] [Related]
19. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpu Mediates HLA-C Downregulation.
Apps R; Del Prete GQ; Chatterjee P; Lara A; Brumme ZL; Brockman MA; Neil S; Pickering S; Schneider DK; Piechocka-Trocha A; Walker BD; Thomas R; Shaw GM; Hahn BH; Keele BF; Lifson JD; Carrington M
Cell Host Microbe; 2016 May; 19(5):686-95. PubMed ID: 27173934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
